by Paolo Strati, and Tait D. Shanafelt

Slides:



Advertisements
Similar presentations
Lymphoma Classification
Advertisements

Non-Hodgkin’s Lymphoma
Introduction to Leukemia
Proposed WHO Classification of Lymphoid neoplasm
Chronic Lymphocytic Leukemia (CLL).
Non-Hodgkin’s Lymphoma
By the end of this session you should know:
Lymphoma Dr. Raid Jastania Dec By the end of this session you should be able to: –Discuss the basis of the classification of lymphomas –Know the.
FAB Classification (French, American, British)
Chronic lymphocytic leukemia (1)
Lymphoproliferative disorders
Non-Hodgkin’s lymphomas-definition and epidemiology
L YMPHOMA FOR THE G ENERALIST Lee Berkowitz, MD. G OALS AND O BJECTIVES 1. Understand the importance of pathology and staging in the approach to management.
Treatment of Non- Hodgkin’s Lymphoma. Precursor B cell Lymphoblastic Leukemia Remission induction with combination therapy Consolidation phase: –High.
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis by Thet Thet Lin, Boitelo T. Letsolo,
Chronic Leukemias. CMLCML CLLCLL CML A clonal disease results from an acquired genetic change in a pluri-potential hemopoietic stem cell within the BM.
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
Lymphoproliferative disorders. Several clinical conditions in which lymphocytes are produced in excessive quantities ( Lymphocytosis) Lymphoma Malignant.
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia by Natali Pflug, Jasmin Bahlo, Tait D. Shanafelt, Barbara.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Non Hodgkin”s Lymphoma -- Histology appearance -- Cell of orgin -- Immunophenotype -- Molecular biology -- Clinical featres -- Prognosis -- Out-come of.
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia by Alessandra Ferrajoli,
MLAB Hematology Keri Brophy-Martinez
Myeloproliferative Lymphoproliferative & Immunoproliferative disorders.
Chronic leukemias أ. م. د. محمد شنين علي العبادي معاون عميد كلية الطب / جامعة كربلاء ورئيس فرع الامراض والطب العدلي M. B. Ch. B. & F. I. C. P.(Hematopathology)
Low Grade Lymphomas: Treatment approaches Parameswaran Venugopal, MD Professor of Medicine Rush University Medical Center.
Date of download: 7/8/2016 From: Narrative Review: Initial Management of Newly Diagnosed, Early-Stage Chronic Lymphocytic Leukemia Ann Intern Med. 2006;145(6):
Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification by Paolo Strati, and.
Viruses That Infect Humans: The DNA Viruses
Lymphoproliferative disorders
Pathology 6 White blood cell and lymph node disorders (1)
Non-Hodgkin’s Lymphoma Thomas Kochuparambil 10/20/10
How I treat LGL leukemia
MBL: mostly benign lymphocytes, but…
Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and.
Nonmyeloablative conditioning for relapsed follicular lymphoma
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
SOX11 holds mantle cell lymphoma’s key to home
Infectious Disease Following Kidney Transplant: Core Curriculum 2010
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia by Charles Koller,
Focus on lymphomas Cancer Cell
Aggiornamento in Ematologia Clinica
Epstein-Barr virus–associated lymphocytosis masquerading as lymphoma
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Long-Lasting Responses with Lenalidomide As Initial Therapy of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)‏ by Paolo Strati, Michael J. Keating,
by Paolo Strati, Michael J. Keating, William G. Wierda, Xavier C
Stage C or not stage C…? by Claire Dearden Blood
Tait D. Shanafelt, MD, Timothy G. Call, MD  Mayo Clinic Proceedings 
CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not by Naoko Ishibe, Maher Albitar, Iman.
Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative.
How I treat refractory CLL
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis by Albert Gutierrez,
Chronic lymphocytic leukemia
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Caught in transformation
Fatal Early-Onset Epstein-Barr Virus–Associated Posttransplantation Lymphoproliferative Disease after Successful Adult Dual-Unit Umbilical Cord Blood.
Cells with CD4 receptor on surface
Mitchell S. Cairo, Willi Woessmann, John Pagel 
by Geling Li, Emily Waite, and Julie Wolfson
LYMPHOPROLIFERATIVE DISORDERS
Varicella-Zoster Virus Disease Is More Frequent after Cord Blood Than after Bone Marrow Transplantation  Kristel Vandenbosch, Philippe Ovetchkine, Martin.
Timeline of common infections in transplant recipients.
Mary Eapen  Biology of Blood and Marrow Transplantation 
How I vaccinate blood and marrow transplant recipients
Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk.
Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in Elderly Patients with Comorbidities: Analysis of the CLL11.
How to establish the diagnosis of LGL leukemia.
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia
Presentation transcript:

by Paolo Strati, and Tait D. Shanafelt Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification by Paolo Strati, and Tait D. Shanafelt Blood Volume 126(4):454-462 July 23, 2015 ©2015 by American Society of Hematology

General approach to the workup of lymphocytosis. General approach to the workup of lymphocytosis. BM, bone marrow; CMV, cytomegalovirus; CTD, connective tissue disease; EBV, Epstein-Barr virus; FL, follicular lymphoma; HCL, hairy cell leukemia; HTLV, human T-lymphotropic virus; LGL, large-granular leukemia; LN, lymph nodes; LPL, lymphoplasmacytic lymphoma; MCL, mantle cell lymphoma; MF, mycosis fungoides; T-PLP, T prolymphocytic leukemia; SMZ, splenic marginal zone lymphoma; T-leu, T-cell leukemia; VZV, varicella zoster virus. Paolo Strati, and Tait D. Shanafelt Blood 2015;126:454-462 ©2015 by American Society of Hematology

Distribution of clonal CLL-like B-cell count in published studies. Distribution of clonal CLL-like B-cell count in published studies. Two main entities can be identified: low-count MBL, usually detected in general population studies, and high-count MBL, usually detected in series of patients referred for lymphocytosis. Reprinted with permission from Rawstron et al.29 Paolo Strati, and Tait D. Shanafelt Blood 2015;126:454-462 ©2015 by American Society of Hematology

Management of early-stage CLL and SLL Management of early-stage CLL and SLL. B2M, β-2-microglobulin; IgG, immunoglobulin G; IVIG, intravenous immunoglobulins; MX, mammogram; PCV, pneumococcus vaccine; PS, performance status; Tdap, tetanus diphtheria, acellular pertussis. Management of early-stage CLL and SLL. B2M, β-2-microglobulin; IgG, immunoglobulin G; IVIG, intravenous immunoglobulins; MX, mammogram; PCV, pneumococcus vaccine; PS, performance status; Tdap, tetanus diphtheria, acellular pertussis. Paolo Strati, and Tait D. Shanafelt Blood 2015;126:454-462 ©2015 by American Society of Hematology